Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290973418> ?p ?o ?g. }
- W4290973418 abstract "Vessel co-option has been demonstrated to mediate colorectal cancer liver metastasis (CRCLM) resistance to antiangiogenic therapy. The current mechanisms underlying vessel co-option have mainly focused on “hijacker” tumor cells, whereas the function of the “hijackee” sinusoidal blood vessels has not been explored. Here, we found that the occurrence of vessel co-option in bevacizumab-resistant CRCLM xenografts was associated with increased expression of fibroblast activation protein α (FAPα) in the co-opted hepatic stellate cells (HSCs), which was dramatically attenuated in HSC-specific conditional Fap-knockout mice bearing CRCLM allografts. Mechanistically, bevacizumab treatment induced hypoxia to upregulate the expression of fibroblast growth factor–binding protein 1 (FGFBP1) in tumor cells. Gain- or loss-of-function experiments revealed that the bevacizumab-resistant tumor cell–derived FGFBP1 induced FAPα expression by enhancing the paracrine FGF2/FGFR1/ERK1/-2/EGR1 signaling pathway in HSCs. FAPα promoted CXCL5 secretion in HSCs, which activated CXCR2 to promote the epithelial-mesenchymal transition of tumor cells and the recruitment of myeloid-derived suppressor cells. These findings were further validated in tumor tissues derived from patients with CRCLM. Targeting FAPα+ HSCs effectively disrupted the co-opted sinusoidal blood vessels and overcame bevacizumab resistance. Our study highlights the role of FAPα+ HSCs in vessel co-option and provides an effective strategy to overcome the vessel co-option–mediated bevacizumab resistance." @default.
- W4290973418 created "2022-08-13" @default.
- W4290973418 creator A5000645986 @default.
- W4290973418 creator A5004565426 @default.
- W4290973418 creator A5006473292 @default.
- W4290973418 creator A5008893965 @default.
- W4290973418 creator A5009562280 @default.
- W4290973418 creator A5016812059 @default.
- W4290973418 creator A5018393057 @default.
- W4290973418 creator A5021950142 @default.
- W4290973418 creator A5023214008 @default.
- W4290973418 creator A5023825932 @default.
- W4290973418 creator A5031103557 @default.
- W4290973418 creator A5036982614 @default.
- W4290973418 creator A5038830876 @default.
- W4290973418 creator A5040885802 @default.
- W4290973418 creator A5041273801 @default.
- W4290973418 creator A5052013557 @default.
- W4290973418 creator A5055561636 @default.
- W4290973418 creator A5059874786 @default.
- W4290973418 creator A5062141342 @default.
- W4290973418 creator A5063240513 @default.
- W4290973418 creator A5066124901 @default.
- W4290973418 creator A5079073938 @default.
- W4290973418 creator A5082372753 @default.
- W4290973418 creator A5091335377 @default.
- W4290973418 creator A5091623331 @default.
- W4290973418 date "2022-10-03" @default.
- W4290973418 modified "2023-10-12" @default.
- W4290973418 title "Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models" @default.
- W4290973418 cites W1629342820 @default.
- W4290973418 cites W1940821365 @default.
- W4290973418 cites W1965834132 @default.
- W4290973418 cites W1970785600 @default.
- W4290973418 cites W1975016799 @default.
- W4290973418 cites W1987490781 @default.
- W4290973418 cites W1989957765 @default.
- W4290973418 cites W1993840794 @default.
- W4290973418 cites W2004150448 @default.
- W4290973418 cites W2005119615 @default.
- W4290973418 cites W2007141982 @default.
- W4290973418 cites W2012255417 @default.
- W4290973418 cites W2035316083 @default.
- W4290973418 cites W2035396091 @default.
- W4290973418 cites W2037199116 @default.
- W4290973418 cites W2046172352 @default.
- W4290973418 cites W2046892973 @default.
- W4290973418 cites W2047521631 @default.
- W4290973418 cites W2058689904 @default.
- W4290973418 cites W2063870592 @default.
- W4290973418 cites W2083019610 @default.
- W4290973418 cites W2087766713 @default.
- W4290973418 cites W2091651881 @default.
- W4290973418 cites W2093024396 @default.
- W4290973418 cites W2099520227 @default.
- W4290973418 cites W2112052543 @default.
- W4290973418 cites W2122135343 @default.
- W4290973418 cites W2136489225 @default.
- W4290973418 cites W2142726098 @default.
- W4290973418 cites W2147091770 @default.
- W4290973418 cites W2151062573 @default.
- W4290973418 cites W2151481753 @default.
- W4290973418 cites W2165062244 @default.
- W4290973418 cites W2334067795 @default.
- W4290973418 cites W2400022769 @default.
- W4290973418 cites W2523349638 @default.
- W4290973418 cites W2523554719 @default.
- W4290973418 cites W2533236332 @default.
- W4290973418 cites W2545015297 @default.
- W4290973418 cites W2555713683 @default.
- W4290973418 cites W2603969536 @default.
- W4290973418 cites W2613180696 @default.
- W4290973418 cites W2745403998 @default.
- W4290973418 cites W2756002490 @default.
- W4290973418 cites W2761578140 @default.
- W4290973418 cites W2761998606 @default.
- W4290973418 cites W2785571650 @default.
- W4290973418 cites W2791965482 @default.
- W4290973418 cites W2802016913 @default.
- W4290973418 cites W2802491677 @default.
- W4290973418 cites W2885447211 @default.
- W4290973418 cites W2912378812 @default.
- W4290973418 cites W2917677528 @default.
- W4290973418 cites W2936075481 @default.
- W4290973418 cites W2977528366 @default.
- W4290973418 cites W2980895491 @default.
- W4290973418 cites W2995665414 @default.
- W4290973418 cites W2996435406 @default.
- W4290973418 cites W2999417355 @default.
- W4290973418 cites W3033089248 @default.
- W4290973418 cites W3044467369 @default.
- W4290973418 cites W3086011748 @default.
- W4290973418 cites W3132971647 @default.
- W4290973418 cites W3160049127 @default.
- W4290973418 cites W3164320506 @default.
- W4290973418 cites W3165286527 @default.
- W4290973418 cites W3170554547 @default.
- W4290973418 cites W3189456876 @default.
- W4290973418 cites W4211037511 @default.
- W4290973418 cites W4211168195 @default.